Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines
Open Access
- 1 July 1992
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 83 (7) , 684-687
- https://doi.org/10.1111/j.1349-7006.1992.tb01966.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Synergistic cytotoxic effects of recombinant human tumor necrosis factor and Etoposide (VP16) or Doxorubicin on A2774 human epithelial ovarian cancer cell lineInternational Journal of Gynecologic Cancer, 1992
- Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: Potentiation of mitoxantrone cytotoxicityGynecologic Oncology, 1991
- Effects of tumor necrosis factor, alone or in combination with topoisomerase‐ii‐targeted drugs, on human lung cancer cell linesInternational Journal of Cancer, 1990
- POTENTIATION OF TOPOISOMERASE INHIBITOR-INDUCED DNA STRAND BREAKAGE AND CYTOTOXICITY BY TUMOR-NECROSIS-FACTOR - ENHANCEMENT OF TOPOISOMERASE ACTIVITY AS A MECHANISM OF POTENTIATION1990
- Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.Journal of Clinical Oncology, 1990
- Tumour necrosis factor as an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1990
- AUGMENTATION OF ANTITUMOR EFFICACY BY THE COMBINATION OF RECOMBINANT TUMOR NECROSIS FACTOR AND CHEMOTHERAPEUTIC-AGENTS INVIVO1989
- Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME‐180 cervical carcinoma line: Modulation by specific inhibitors of DNA topoisomerase IIJournal of Cellular Biochemistry, 1989
- Recombinant Human Tumor Necrosis Factor Alone and With Chemotherapeutic AgentsArchives of Surgery, 1989
- Tumor Necrosis Factor (TNF)Science, 1985